Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Namita Jaggi is active.

Publication


Featured researches published by Namita Jaggi.


International Journal of Infectious Diseases | 2013

Impact of an International Nosocomial Infection Control Consortium multidimensional approach on central line-associated bloodstream infection rates in adult intensive care units in eight cities in India

Namita Jaggi; Camilla Rodrigues; Victor D. Rosenthal; Subhash Todi; Sweta Shah; Narinder Saini; Arpita Dwivedy; F.E. Udwadia; Preeti Mehta; Murali Chakravarthy; Sanjeev Singh; Samir Sahu; Deepak Govil; Ashit Hegd; Farahad Kapadia; Arpita Bhakta; M Bhattacharyya; Tanu Singhal; Reshma Naik; Vatsal Kothari; Amit Gupta; Suvin Shetty; Sheena Binu; Preethi Pinto; Aruna Poojary; Geeta Koppikar; Lata Bhandarkar; Shital Jadhav; Neeraj Chavan; Shweta Bahirune

OBJECTIVE To evaluate the impact of the International Nosocomial Infection Control Consortium (INICC) multidimensional infection control approach on central line-associated bloodstream infection (CLABSI) rates in eight cities of India. METHODS This was a prospective, before-and-after cohort study of 35650 patients hospitalized in 16 adult intensive care units of 11 hospitals. During the baseline period, outcome surveillance of CLABSI was performed, applying the definitions of the CDC/NHSN (US Centers for Disease Control and Prevention/National Healthcare Safety Network). During the intervention, the INICC approach was implemented, which included a bundle of interventions, education, outcome surveillance, process surveillance, feedback on CLABSI rates and consequences, and performance feedback. Random effects Poisson regression was used for clustering of CLABSI rates across time periods. RESULTS During the baseline period, 9472 central line (CL)-days and 61 CLABSIs were recorded; during the intervention period, 80898 CL-days and 404 CLABSIs were recorded. The baseline rate was 6.4 CLABSIs per 1000 CL-days, which was reduced to 3.9 CLABSIs per 1000 CL-days in the second year and maintained for 36 months of follow-up, accounting for a 53% CLABSI rate reduction (incidence rate ratio 0.47, 95% confidence interval 0.31-0.70; p=0.0001). CONCLUSIONS Implementing the six components of the INICC approach simultaneously was associated with a significant reduction in the CLABSI rate in India, which remained stable during 36 months of follow-up.


Antimicrobial Resistance and Infection Control | 2012

Control of multidrug resistant bacteria in a tertiary care hospital in India

Namita Jaggi; Pushpa Sissodia; Lalit Sharma

BackgroundThe objective of this study was to assess the impact of antimicrobial stewardship programs on the multidrug resistance patterns of bacterial isolates. The study comprised an initial retrospective analysis of multidrug resistance in bacterial isolates for one year (July 2007-June 2008) followed by prospective evaluation of the impact of Antimicrobial Stewardship programs on resistance for two years and nine months (July 2008-March 2011).SettingA 300-bed tertiary care private hospital in Gurgaon, Haryana (India)FindingsMethodsStudy Design• July 2007 to June 2008: Resistance patterns of bacterial isolates were studied.• July 2008: Phase I intervention programme Implementation of an antibiotic policy in the hospital.• July 2008 to June 2010: Assessment of the impact of the Phase I intervention programme.• July 2010 to March 2011: Phase II intervention programme: Formation and effective functioning of the antimicrobial stewardship committee. Statistical correlation of the Defined daily dose (DDD) for prescribed drugs with the antimicrobial resistance of Gram negatives.ResultsPhase I intervention programme (July 2008) resulted in a decrease of 4.47% in ESBLs (E.coli and Klebsiella) and a significant decrease of 40.8% in carbapenem-resistant Pseudomonas. Phase II intervention (July 2010) brought a significant reduction (24.7%) in carbapenem-resistant Pseudomonas. However, the resistance in the other Gram negatives (E.coli, Klebsiella, and Acinetobacter) rose and then stabilized. A positive correlation was observed in Pseudomonas and Acinetobacter with carbapenems and cefoperazone-sulbactam.Piperacillin-tazobactam showed a positive correlation with Acinetobacter only. E.coli and Klebsiella showed positive correlation with cefoparazone-sulbactam and piperacillin-tazobactam.ConclusionAn antimicrobial stewardship programme with sustained and multifaceted efforts is essential to promote the judicious use of antibiotics.


Epidemiology and Infection | 2013

Effectiveness of a multidimensional approach for prevention of ventilator-associated pneumonia in 21 adult intensive-care units from 10 cities in India: findings of the International Nosocomial Infection Control Consortium (INICC).

Yatin Mehta; Namita Jaggi; Victor D. Rosenthal; C. Rodrigues; Subhash Todi; N. Saini; F. E. Udwadia; A. Karlekar; V. Kothari; Sheila Nainan Myatra; Murali Chakravarthy; Sanjeev Singh; A. Dwivedy; Nagamani Sen; S. Sahu

We report on the effect of the International Nosocomial Infection Control Consortiums (INICC) multidimensional approach for the reduction of ventilator-associated pneumonia (VAP) in adult patients hospitalized in 21 intensive-care units (ICUs), from 14 hospitals in 10 Indian cities. A quasi-experimental study was conducted, which was divided into baseline and intervention periods. During baseline, prospective surveillance of VAP was performed applying the Centers for Disease Control and Prevention/National Healthcare Safety Network definitions and INICC methods. During intervention, our approach in each ICU included a bundle of interventions, education, outcome and process surveillance, and feedback of VAP rates and performance. Crude stratified rates were calculated, and by using random-effects Poisson regression to allow for clustering by ICU, the incidence rate ratio for each time period compared with the 3-month baseline was determined. The VAP rate was 17.43/1000 mechanical ventilator days during baseline, and 10.81 for intervention, showing a 38% VAP rate reduction (relative risk 0.62, 95% confidence interval 0.5-0.78, P = 0.0001).


Antimicrobial Resistance and Infection Control | 2016

APSIC guide for prevention of Central Line Associated Bloodstream Infections (CLABSI)

Moi Lin Ling; Anucha Apisarnthanarak; Namita Jaggi; Glenys Harrington; Keita Morikane; Le Thi Anh Thu; Patricia T.Y. Ching; Victoria Villanueva; Zhiyong Zong; Jae Sim Jeong; Chun-Ming Lee

This document is an executive summary of the APSIC Guide for Prevention of Central Line Associated Bloodstream Infections (CLABSI). It describes key evidence-based care components of the Central Line Insertion and Maintenance Bundles and its implementation using the quality improvement methodology, namely the Plan-Do-Study-Act (PDSA) methodology involving multidisciplinary process and stakeholders. Monitoring of improvement over time with timely feedback to stakeholders is a key component to ensure the success of implementing best practices. A surveillance program is recommended to monitor outcomes and adherence to evidence-based central line insertion and maintenance practices (compliance rate) and identify quality improvement opportunities and strategically targeting interventions for the reduction of CLABSI.


Infection Control and Hospital Epidemiology | 2016

Device-Associated Infection Rates in 20 Cities of India, Data Summary for 2004-2013: Findings of the International Nosocomial Infection Control Consortium.

Yatin Mehta; Namita Jaggi; Victor D. Rosenthal; Maithili Kavathekar; Asmita Sakle; Nita Munshi; Murali Chakravarthy; Subhash Todi; Narinder Saini; Camilla Rodrigues; Karthikeya K. Varma; Rekha Dubey; Mohammad Mukhit Kazi; F.E. Udwadia; Sheila Nainan Myatra; Sweta Shah; Arpita Dwivedy; Anil Karlekar; Sanjeev Singh; Nagamani Sen; Kashmira Limaye-Joshi; Suneeta Sahu; Nirav Pandya; Purva Mathur; Samir Sahu; Suman P. Singh; Anil Kumar Bilolikar; Siva Kumar; Preeti Mehta; Vikram V. Padbidri

OBJECTIVE To report the International Nosocomial Infection Control Consortium surveillance data from 40 hospitals (20 cities) in India 2004-2013. METHODS Surveillance using US National Healthcare Safety Networks criteria and definitions, and International Nosocomial Infection Control Consortium methodology. RESULTS We collected data from 236,700 ICU patients for 970,713 bed-days Pooled device-associated healthcare-associated infection rates for adult and pediatric ICUs were 5.1 central line-associated bloodstream infections (CLABSIs)/1,000 central line-days, 9.4 cases of ventilator-associated pneumonia (VAPs)/1,000 mechanical ventilator-days, and 2.1 catheter-associated urinary tract infections/1,000 urinary catheter-days In neonatal ICUs (NICUs) pooled rates were 36.2 CLABSIs/1,000 central line-days and 1.9 VAPs/1,000 mechanical ventilator-days Extra length of stay in adult and pediatric ICUs was 9.5 for CLABSI, 9.1 for VAP, and 10.0 for catheter-associated urinary tract infections. Extra length of stay in NICUs was 14.7 for CLABSI and 38.7 for VAP Crude extra mortality was 16.3% for CLABSI, 22.7% for VAP, and 6.6% for catheter-associated urinary tract infections in adult and pediatric ICUs, and 1.2% for CLABSI and 8.3% for VAP in NICUs Pooled device use ratios were 0.21 for mechanical ventilator, 0.39 for central line, and 0.53 for urinary catheter in adult and pediatric ICUs; and 0.07 for mechanical ventilator and 0.06 for central line in NICUs. CONCLUSIONS Despite a lower device use ratio in our ICUs, our device-associated healthcare-associated infection rates are higher than National Healthcare Safety Network, but lower than International Nosocomial Infection Control Consortium Report.


Journal of clinical and diagnostic research : JCDR | 2012

Multimodal supervision programme to reduce catheter associated urinary tract infections and its analysis to enable focus on labour and cost effective infection control measures in a tertiary care hospital in India.

Namita Jaggi; Pushpa Sissodia

BACKGROUND Catheter Associated Urinary Tract Infections (CAUTI) contribute 30%-40% of all the nosocomial infections and they are associated with substantially increased institutional death rates. A multimodal supervision program which incorporates training of the staff with respect to infection control measures can be effective in reducing the CAUTIs in hospitals. AIM To assess the impact of a multimodal UTI supervision program on the CAUTI rates over a year, from January 2009 to December 2009, in a tertiary care hospital in India. SETTING A 215 bedded tertiary care private hospital. MATERIALS AND METHODS The CAUTI rates were analyzed for the first 6 months (January 2009-June 2009). A UTI supervision program was instituted in the month of July 2009, which included training with respect to the standard protocols for the sample collection and diagnosis, the bundle components of the urinary catheter checklist and hand hygiene practices. The impact was assessed as per the CAUTI rates in the subsequent months. RESULTS The average CAUTI rate was reduced by 47.1% (from 10.6 to 5.6) after the introduction of the supervision program. This study presented the mean age of the patients with CAUTIs as 54.5 years and it showed an approximately equal contribution of both the sexes (52.94% in males and 47.05% in females). The impact analysis of the supervision program showed a reduction of 8.7% (from 23 days to 21 days) during the average duration of the catheterization. The adherence to the components of the urinary catheter check list was increased by 44.4% (p=0.069) and the hand hygiene compliance was increased by 56.4% (p=0.004) respectively after the interventions. Components like bladder irrigation and practising perineal cleaning were found to show no effect on the CAUTI rates. CONCLUSION The most common labour and cost effective infection control measures as revealed by the supervision programme were adherence to the urinary catheter checklist components (indication for catheter insertion and change, asepsis maintenance during and after the catheter insertion and avoiding urine reflux) and hand hygiene practices, whereas bladder irrigation and practising perineal cleaning thrice a day were unnecessary measures.


BMC Proceedings | 2011

Acinetobacter Baumannii isolates: epidemiology, antibiogram and nosocomial status studied over a 25 month period in a tertiary care hospital in India

Namita Jaggi; Pushpa Sissodia; Lalit Sharma

The emergence of Acinetobacter baumannii as an epidemiologically significant nosocomial agent based on its epidemiology, antibiogram patterns and clinical correlation was explored in a 25 month study at a tertiary care hospital in India.


Antimicrobial Resistance and Infection Control | 2013

P002: The analysis and impact of three successive intervention programmes directed to reduce central line associated blood stream infections over a four year period in a tertiary care hospital in India

Namita Jaggi; P Nirwan; E Naryana; Kp Kaur

Central line associated blood stream infections (CLABSI) in the ICU are associated with significant morbidity, mortality and costs. Supervision programmes have shown to decrease CLABSI rates but repeated interventions are required.


Journal of Patient Safety and Infection Control | 2013

Surgical Site Infection

Namita Jaggi; Deepak Govil; T.S. Jain; Raman Sardana; Leena Mendiratta

ABSTRACT The incidence of surgical site infections (SSI) depends upon the patient risk-factors, surgical procedure, and practices observed by the operating team. This review aims at examining existing guidelines upon prevention of SSI. Various recommendations pertaining to pre-operative, operative and postoperative phase were evaluated. Implementation of measures like meticulous surgical scrubbing, and surgical site preparation, appropriate antimicrobial prophylaxis (right antimicrobial, dose, timing, and duration), right operative environment, observing strict antisepsis, and glucose control have majorly contributed towards reducing infections. Surveillance strategies towards SSI are essential as they help in guiding towards appropriate implementation of various measures.


Journal of Patient Safety and Infection Control | 2013

Newer Antiparasitic Agents

Namita Jaggi

ABSTRACT Development of drug resistance, insecticide resistance and appearance of newer antiparasitic strains are some of the current challenges being faced by healthcare professionals in the field of parasitology. Highlighting the opportunities for antiparasitic drug discovered and the progress in recent years is the main objective of this review. Very few antiparasitic drugs have been discovered in the recent past, as compared to the other drugs of the pharmaceutical industry. Public-private partnerships have proven beneficial in providing funds to some parasite-focused projects. Some countries, especially the poor, undeveloped still have a problem due to the neglect of certain parasitic diseases which are unique to their epidemiology. There is a need to change prescribing patterns of clinicians, promote research in anti-parasitic drugs, and increase awareness of infection prevention and control in order to minimize the spread of parasitic diseases especially as newer anti-parasitic agents are scarce on the horizon.

Collaboration


Dive into the Namita Jaggi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sanjeev Singh

Amrita Institute of Medical Sciences and Research Centre

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Victor D. Rosenthal

Mexican Social Security Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nagamani Sen

Christian Medical College

View shared research outputs
Researchain Logo
Decentralizing Knowledge